US Drug Recall Register
Class II · Moderate risk Ongoing Initiated Oct 22, 2024 (2 years ago)

Morphine Sulfate Extended-Release Tablets 30 mg, 100-count bottles, Rx Only…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Failed Impurities/Degradation Specification

What was recalled

Morphine Sulfate Extended-Release Tablets 30 mg, 100-count bottles, Rx Only, Manufactured by Mayne Pharma, Greenville, NC 27834, NDC 51862-186-01.

Recalling firm
Dr. Reddy's Laboratories, Inc.
NDC code
51862-186-01
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0037-2025

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Morphine recalls

See all